For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies
- Ono Venture Investment Invests in Mozart Therapeutics.
(Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Disease)
- Ono Venture Investment Invests in Violet Therapeutics.
(Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV))
- Ono Venture Investment makes a follow-on investment in Mediar Therapeutics.
(Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies)